- Home
- EDIT vs BMRC Comparison
EDIT vs BMRC Comparison
Compare EDIT & BMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EDIT | BMRC |
|---|---|---|
| Founded | 2013 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.8M | 436.4M |
| IPO Year | 2016 | 2007 |
Fundamental Metrics
Financial Performance| Metric | EDIT | BMRC |
|---|---|---|
| Price | $2.69 | $27.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $5.30 | ★ $28.67 |
| AVG Volume (30 Days) | ★ 2.3M | 134.1K |
| Earning Date | 05-11-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 3.92% |
| EPS Growth | ★ 37.50 | N/A |
| EPS | N/A | ★ 1.11 |
| Revenue | ★ $31,937,000.00 | N/A |
| Revenue This Year | N/A | $391.81 |
| Revenue Next Year | N/A | $6.13 |
| P/E Ratio | ★ N/A | $25.23 |
| Revenue Growth | ★ 132.64 | N/A |
| 52 Week Low | $1.66 | $22.50 |
| 52 Week High | $4.54 | $30.92 |
Technical Indicators
Market Signals| Indicator | EDIT | BMRC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
About BMRC Bank of Marin Bancorp
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties, and others. The majority of its revenue comes from interest income.